AEON Biopharma Inc. has granted a total of 392,158 restricted stock units (RSUs) of the company's common stock to newly hired non-executive employees. The RSUs were approved under the company's 2025 Inducement Incentive Plan, with a grant date of December 11, 2025. Vesting will occur over four years, with 25% of the RSUs vesting on each annual anniversary of the vesting commencement date.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. AEON Biopharma Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 9605422) on December 19, 2025, and is solely responsible for the information contained therein.